BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28839258)

  • 41. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
    Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypoxia-mediated cancer stem cells in pseudopalisades with activation of hypoxia-inducible factor-1α/Akt axis in glioblastoma.
    Inukai M; Hara A; Yasui Y; Kumabe T; Matsumoto T; Saegusa M
    Hum Pathol; 2015 Oct; 46(10):1496-505. PubMed ID: 26256949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypoxia-inducible factor-2α (HIF-2α), but not HIF-1α, is essential for hypoxic induction of class III β-tubulin expression in human glioblastoma cells.
    Bordji K; Grandval A; Cuhna-Alves L; Lechapt-Zalcman E; Bernaudin M
    FEBS J; 2014 Dec; 281(23):5220-36. PubMed ID: 25244496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
    Tian T; Mingyi M; Qiu X; Qiu Y
    Oncotarget; 2016 Nov; 7(48):79584-79595. PubMed ID: 27792996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma.
    Han MZ; Wang S; Zhao WB; Ni SL; Yang N; Kong Y; Huang B; Chen AJ; Li XG; Wang J; Wang DH
    EBioMedicine; 2019 May; 43():159-170. PubMed ID: 30987862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulated AHIF-mediated radioresistance in glioblastoma.
    Liao K; Ma X; Chen B; Lu X; Hu Y; Lin Y; Huang R; Qiu Y
    Biochem Biophys Res Commun; 2019 Feb; 509(2):617-623. PubMed ID: 30606477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LBH589 Inhibits Glioblastoma Growth and Angiogenesis Through Suppression of HIF-1α Expression.
    Yao ZG; Li WH; Hua F; Cheng HX; Zhao MQ; Sun XC; Qin YJ; Li JM
    J Neuropathol Exp Neurol; 2017 Dec; 76(12):1000-1007. PubMed ID: 29136455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.
    Bhat KPL; Balasubramaniyan V; Vaillant B; Ezhilarasan R; Hummelink K; Hollingsworth F; Wani K; Heathcock L; James JD; Goodman LD; Conroy S; Long L; Lelic N; Wang S; Gumin J; Raj D; Kodama Y; Raghunathan A; Olar A; Joshi K; Pelloski CE; Heimberger A; Kim SH; Cahill DP; Rao G; Den Dunnen WFA; Boddeke HWGM; Phillips HS; Nakano I; Lang FF; Colman H; Sulman EP; Aldape K
    Cancer Cell; 2013 Sep; 24(3):331-46. PubMed ID: 23993863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypoxia-Driven M2-Polarized Macrophages Facilitate Cancer Aggressiveness and Temozolomide Resistance in Glioblastoma.
    Zhang G; Tao X; Ji B; Gong J
    Oxid Med Cell Longev; 2022; 2022():1614336. PubMed ID: 36046687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
    Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
    Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
    Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
    Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction and Assessment of Hypoxia in Glioblastoma Cells In Vitro.
    Gagner JP; Lechpammer M; Zagzag D
    Methods Mol Biol; 2018; 1741():111-123. PubMed ID: 29392695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme.
    Fisher T; Galanti G; Lavie G; Jacob-Hirsch J; Kventsel I; Zeligson S; Winkler R; Simon AJ; Amariglio N; Rechavi G; Toren A
    Cancer J; 2007; 13(5):335-44. PubMed ID: 17921733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of Hypoxia and the Hypoxic Response in Tumor Xenografts.
    Böğürcü N; Seidel S; Garvalov BK; Acker T
    Methods Mol Biol; 2018; 1742():283-300. PubMed ID: 29330809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.
    Besse A; Sana J; Lakomy R; Kren L; Fadrus P; Smrcka M; Hermanova M; Jancalek R; Reguli S; Lipina R; Svoboda M; Slampa P; Slaby O
    Tumour Biol; 2016 Jun; 37(6):7719-27. PubMed ID: 26692101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma.
    Foltyn M; Luger AL; Lorenz NI; Sauer B; Mittelbronn M; Harter PN; Steinbach JP; Ronellenfitsch MW
    Br J Cancer; 2019 Mar; 120(5):481-487. PubMed ID: 30745581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma.
    Huang M; Liu T; Ma P; Mitteer RA; Zhang Z; Kim HJ; Yeo E; Zhang D; Cai P; Li C; Zhang L; Zhao B; Roccograndi L; O'Rourke DM; Dahmane N; Gong Y; Koumenis C; Fan Y
    J Clin Invest; 2016 May; 126(5):1801-14. PubMed ID: 27043280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma.
    Beig N; Patel J; Prasanna P; Hill V; Gupta A; Correa R; Bera K; Singh S; Partovi S; Varadan V; Ahluwalia M; Madabhushi A; Tiwari P
    Sci Rep; 2018 Jan; 8(1):7. PubMed ID: 29311558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma.
    Gao Y; Zhang E; Liu B; Zhou K; He S; Feng L; Wu G; Cao M; Wu H; Cui Y; Zhang X; Liu X; Wang Y; Gao Y; Bian X
    J Cell Mol Med; 2019 Sep; 23(9):6228-6237. PubMed ID: 31282108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
    Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
    PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.